Vatistas N J, Snyder J R, Hildebrand S V, Harmon F A, Woliner M J, Barry S J, Nieto J, Henry P, Enos L R, Magliano D, Brown S A, Drake C
Department of Surgical and Radiological Sciences, University of California, Davis 95616, USA.
Am J Vet Res. 1996 May;57(5):762-70.
To determine the effects of the 21-aminosteroid, U-74389G, on reperfusion of the equine jejunum, using total (TVO) and partial (PVO) vascular occlusion during the ischemic period.
TVO: 16 healthy horses were randomly allotted to 3 groups-4 horses received the vehicle alone, 6 horses received a low dosage (3 mg/kg o body weight), and 6 horses a high dosage (10 mg/kg) of U-7438G. PVO: 10 healthy horses were randomly allotted to 2 groups--5 horses received the vehicle alone, and 5 horses received the low dosage (3 mg/kg) of U-74389G.
TVO was induced for 1 hour followed by 2 hours of reperfusion. During PVO, blood flow was reduced to 20% of baseline for 2 hours, followed by 2 hours of reperfusion. For both models, either the vehicle alone or the drug was given 15 minutes prior to reperfusion. Samples were obtained before, during, and after ischemia for determination of myeloperoxidase (MPO) activity, malondealdehyde (MDA) concentration, concentration of conjugated dienes (PVO experiment only), and morphometric analysis.
TVO: tissue concentration of MDA and MPO activity were not altered in any group by ischemia or reperfusion. During ischemia, mucosal volume and surface area were reduced. After reperfusion, no further reduction occurred. After initial decrease in submucosal volume during ischemia, there was a significant increase after reperfusion in the vehicle-only group (P < 0.05). PVO: there were no alterations in the concentration of either MDA or conjugated dienes. There was significant increase in the activity of MPO during ischemia and reperfusion (P < 0.05). These effects were similar for the vehicle-only and drug groups. During ischemia, there was a significant decrease in mucosal surface area and volume (P < 0.05), that was continued during reperfusion for the vehicle-only (P < 0.05). Submucosal volume increased during ischemia and reperfusion.
Reduced blood flow during ischemia (PVO group) caused continued loss in mucosal volume and surface area during reperfusion. At the dosage given, the 21-aminosteroid, U-74389G, was not effective in preventing continued reduction in mucosal volume and surface area after restoration of blood supply in the horses subjected to reduced blood flow.
在缺血期采用完全血管闭塞(TVO)和部分血管闭塞(PVO)的方法,确定21 - 氨基类固醇U - 74389G对马空肠再灌注的影响。
TVO:16匹健康马随机分为3组,4匹马仅接受赋形剂,6匹马接受低剂量(3mg/kg体重)的U - 74389G,6匹马接受高剂量(10mg/kg)的U - 74389G。PVO:10匹健康马随机分为2组,5匹马仅接受赋形剂,5匹马接受低剂量(3mg/kg)的U - 74389G。
TVO诱导1小时,随后再灌注2小时。在PVO期间,血流量降至基线的20%,持续2小时,随后再灌注2小时。对于两种模型,在再灌注前15分钟给予单独的赋形剂或药物。在缺血前、缺血期间和缺血后采集样本,用于测定髓过氧化物酶(MPO)活性、丙二醛(MDA)浓度、共轭二烯浓度(仅PVO实验)和形态计量分析。
TVO:缺血或再灌注未使任何组的MDA组织浓度和MPO活性发生改变。缺血期间,黏膜体积和表面积减小。再灌注后,未进一步减小。缺血期间黏膜下层体积最初减小后,仅接受赋形剂的组在再灌注后显著增加(P < 0.05)。PVO:MDA或共轭二烯浓度均无改变。缺血和再灌注期间MPO活性显著增加(P < 0.05)。仅接受赋形剂组和药物组的这些影响相似。缺血期间,黏膜表面积和体积显著减小(P < 0.05),仅接受赋形剂的组在再灌注期间仍持续减小(P < 0.05)。黏膜下层体积在缺血和再灌注期间增加。
缺血期间血流量减少(PVO组)导致再灌注期间黏膜体积和表面积持续损失。在所给剂量下,21 - 氨基类固醇U - 74389G在防止血流量减少的马恢复供血后黏膜体积和表面积持续减小方面无效。